US pharmaceuticals giant Johnson &amp; Johnson on Thursday announced it was buying Swiss medical firm Actelion for $30 billion (27.9 billion euros).Johnson &amp; Johnson&#8217;s CEO and chairman Alex Gorsky said in a statement that the acquisition of Actelion, a leader in medicines treating high blood pressure, offered &#8220;compelling value&#8221; to shareholders in both companies.-AFP 